Natural Beauty Bio-Technology Limited (0157.HK)
HKD 0.46
(-3.16%)
HKD 0.46
(-3.16%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.49 Million HKD | -41.93% |
| 2022 | 6.02 Million HKD | -36.47% |
| 2021 | 9.48 Million HKD | 315.69% |
| 2020 | 2.28 Million HKD | -78.07% |
| 2019 | 10.4 Million HKD | 0.0% |
| 2018 | - HKD | 0.0% |
| 2017 | - HKD | 0.0% |
| 2016 | - HKD | 0.0% |
| 2015 | - HKD | 0.0% |
| 2014 | - HKD | 0.0% |
| 2013 | - HKD | 0.0% |
| 2012 | - HKD | 0.0% |
| 2011 | - HKD | 0.0% |
| 2010 | - HKD | 0.0% |
| 2009 | - HKD | 0.0% |
| 2008 | - HKD | 0.0% |
| 2007 | - HKD | 0.0% |
| 2006 | - HKD | 0.0% |
| 2005 | - HKD | 0.0% |
| 2004 | - HKD | 0.0% |
| 2003 | - HKD | 0.0% |
| 2002 | - HKD | 0.0% |
| 2001 | - HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 2.08 Million HKD | 0.0% |
| 2023 Q2 | 4.69 Million HKD | 0.0% |
| 2023 FY | 3.49 Million HKD | -41.93% |
| 2023 Q4 | 3.49 Million HKD | 0.0% |
| 2022 Q2 | 7.56 Million HKD | 0.0% |
| 2022 Q4 | 6.02 Million HKD | 0.0% |
| 2022 FY | 6.02 Million HKD | -36.47% |
| 2021 Q2 | 10.76 Million HKD | 0.0% |
| 2021 FY | 9.48 Million HKD | 315.69% |
| 2021 Q4 | 9.48 Million HKD | 0.0% |
| 2020 FY | 2.28 Million HKD | -78.07% |
| 2020 Q2 | 23.7 Million HKD | 0.0% |
| 2020 Q4 | 2.28 Million HKD | 0.0% |
| 2019 Q4 | 10.4 Million HKD | 0.0% |
| 2019 FY | 10.4 Million HKD | 0.0% |
| 2019 Q2 | 16.45 Million HKD | 0.0% |
| 2018 Q2 | - HKD | 0.0% |
| 2018 FY | - HKD | 0.0% |
| 2018 Q4 | - HKD | 0.0% |
| 2017 Q4 | - HKD | 0.0% |
| 2017 FY | - HKD | 0.0% |
| 2017 Q2 | - HKD | 0.0% |
| 2016 FY | - HKD | 0.0% |
| 2016 Q2 | - HKD | 0.0% |
| 2016 Q4 | - HKD | 0.0% |
| 2015 Q4 | - HKD | 0.0% |
| 2015 FY | - HKD | 0.0% |
| 2015 Q2 | - HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 FY | - HKD | 0.0% |
| 2014 Q2 | - HKD | 0.0% |
| 2013 FY | - HKD | 0.0% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q2 | - HKD | 0.0% |
| 2012 FY | - HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2012 Q4 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2011 Q4 | - HKD | 0.0% |
| 2011 FY | - HKD | 0.0% |
| 2010 Q2 | - HKD | 0.0% |
| 2010 FY | - HKD | 0.0% |
| 2010 Q4 | - HKD | 0.0% |
| 2009 Q4 | - HKD | 0.0% |
| 2009 FY | - HKD | 0.0% |
| 2008 FY | - HKD | 0.0% |
| 2007 FY | - HKD | 0.0% |
| 2006 FY | - HKD | 0.0% |
| 2005 FY | - HKD | 0.0% |
| 2004 FY | - HKD | 0.0% |
| 2003 FY | - HKD | 0.0% |
| 2002 FY | - HKD | 0.0% |
| 2001 FY | - HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Innovative Pharmaceutical Biotech Limited | 661.64 Million HKD | 99.471% |
| China Overseas Nuoxin International Holdings Limited | 9.2 Million HKD | 61.987% |
| Prosperous Future Holdings Limited | 6.33 Million HKD | 44.774% |
| Huasheng International Holding Limited | 207.84 Million HKD | 98.317% |
| Fourace Industries Group Holdings Limited | 2.39 Million HKD | -46.36% |
| Evergreen Products Group Limited | 35.17 Million HKD | 90.055% |
| EC Healthcare | 783.75 Million HKD | 99.554% |
| Ming Fai International Holdings Limited | 2.16 Million HKD | -61.645% |
| Blue Moon Group Holdings Limited | 101.55 Million HKD | 96.555% |
| SuperRobotics Holdings Limited | 138.44 Million HKD | 97.473% |
| Takbo Group Holdings Limited | 7.72 Million HKD | 54.736% |
| Hyfusin Group Holdings Limited | 8.66 Million HKD | 59.649% |